ABT: Rasio kapitalisasi marang pendapatan Abbott Labs

Steady growth for Abbott Laboratories (ABT) is driven by the implementation of innovative glucose monitoring systems and the expansion of its medtech portfolio. The price-to-sales ratio visualizes this trend, with the metric holding around 3.90. Revenues are based on the sale of diagnostic equipment and specialized nutrition. Operational resilience is supported by a balanced combination of in-house manufacturing plants and diversified component outsourcing.

Abbott (ABT): Multiplikator P/S saka 04.07.2022 nganti 13.11.2026

Rincian metrik lan analitis perusahaan Abbott Laboratories Inc. (ABT)

- kuotasi saiki lan rata-rata prakiraan nilai:

Rega bursa abbott.com|ABT - Prakiraan konsensus analis

- informasi kapitalisasi pasar:

Kapitalisasi pasar Abbott Laboratories Inc.|ABT - Nilai Perusahaan

- rincian valuasi buku bisnis:

Aset Bersih saben Saham Abbott|ABT - Kapitalisasi Buku|Rasio Kapitalisasi marang Aset Bersih abbott.com|ABT - Total Aset Perusahaan

- statistik kawajiban utang lan likuiditas:

- data bathi resik lan rasio valuasi:

ABT - Penghasilan resik|Proyeksi bathi mangsa ngarep Abbott Laboratories|ABT - Pangali P/E|Kapitalisasi marang proyeksi bathi Abbott Labs|ABT - Rasio rega marang bathi tumrap wutah|Rasio nilai perusahaan marang bathi operasional sadurunge panyusutan Abbott Laboratories Inc.|ABT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Abbott|ABT - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan abbott.com|ABT - Wutah bathi saben saham ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Abbott Laboratories

- rincian pendapatan lan dodolan emiten:

ABT - Dodolan perusahaan|Prakiraan volume pendapatan perusahaan abbott.com|ABT - Multiplikator P/S|Multiplikator Forward P/S Abbott Laboratories Inc.

Ringkesan analitik perusahaan:abbott.com, ABT

By analyzing the revenue multiple dynamics of Abbott Laboratories (ABT), an investor compares the business's market value with its actual operating revenues, allowing them to filter out speculative noise from fundamental growth. The price-to-sales ratio confirms the effectiveness of medical segment diversification and management competence, determining the extent to which the asset's current price is justified by the scale of the generated cash flow.

Perusahaan pesaing

TMO - Rega marang dodolan|Multiplikator P/S GEHC (GE HealthCare Technologies)|MTD: Rasio kapitalisasi marang pendapatan|Waters Corp. - Multiplikator P/S|Koefisien rega marang pendapatan Bio-Techne Inc. TECH|BRKR: Multiplikator P/S|Kapitalisasi marang pendapatan azenta.com|VREX (Varex Imaging Corporation) - Multiplikator P/S|Multiplikator P/S Semler Scientific Inc|Rasio rega marang pendapatan Butterfly iQ (BFLY)|Rasio rega marang pendapatan MLAB (Mesa Laboratories Corp.)|Quantum-Si - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan NNOX|Quanterix - Multiplikator P/S|Rega marang dodolan 908 Devices Inc|capsovision.com (CV) - Rasio rega marang pendapatan|Multiplikator rega marang pendapatan MaxCyte Inc MXCT|Kapitalisasi marang pendapatan RPID|Multiplikator P/S seer.bio|Multiplikator P/S HYPR|Koefisien rega marang pendapatan FONAR Corp.|Rasio rega marang pendapatan Daxor DXR|MDAI (spectral-ai.com) - Rasio rega marang dodolan|VIVS - Rasio rega marang pendapatan|aclarion.com (ACON) - Kapitalisasi marang pendapatan|AKYA: Multiplikator P/S|Rega marang dodolan ThermoGenesis Holdings, Inc. (THMO)|Rasio rega marang pendapatan Talis Biomedical Corp.|Rasio kapitalisasi marang pendapatan TTOO (T2 Biosystems Inc)